Understanding Multiple Myeloma: An Overview of Causes and Risk Factors
Multiple myeloma is a cancer of plasma cells. Risk factors include age, male gender. learn about signs, diagnosis, causes, symptoms and treatment | GetWellGo
Multiple myeloma is not usually a hereditary condition, but there is some indication that genetics might be involved. Although most instances are sporadic, research indicates that people with a close relative (parent or sibling) who has had multiple myeloma or a similar plasma cell disorder (such as monoclonal gammopathy of undetermined significance, or MGUS) might have a slightly increased risk of developing the disease. Nevertheless, the overall hereditary risk is low.
Genetic mechanisms that could play a role include immune system regulation and DNA repair variation, but no inherited gene mutation has been discovered as a direct etiology. Environmental and lifestyle exposures, including ionizing radiation, specific chemicals (e.g., benzene), and chronic inflammation, are thought to play a larger role in the development of multiple myeloma than inherited characteristics.
What Causes Multiple Myeloma Cancer?
Multiple myeloma results from uncontrolled proliferation of abnormal plasma cells in the bone marrow. The multiple myeloma causes are still not clear, but a combination of factors precipitates its development:
1. Genetic Mutations
Alteration in the plasma cell DNA may result in unlimited cell growth. Some of the frequent genetic anomalies in multiple myeloma involve mutations in MYC, TP53, and RAS genes and chromosomal translocations t(14q32) involving chromosomes 14q32 (IgH gene rearrangement).
2. Environmental & Occupational Exposure
Radiation and some chemicals such as benzene, pesticides, and Agent Orange have been associated with an elevated risk. Individuals who work in agriculture, oil refining, or petrochemical industries are said to be at a greater risk.
3. Chronic Immune Stimulation & Infections
Conditions that lead to prolonged immune stimulation, such as chronic infection or autoimmune diseases, have been associated with an elevated risk of plasma cell disorders.
4. Monoclonal Gammopathy of Undetermined Significance (MGUS)
MGUS is a pre-malignant condition where the abnormal plasma cells secrete M proteins (monoclonal proteins) but do not make the person ill. Approximately 1% of individuals with MGUS develop multiple myeloma yearly.
5. Age & Gender
Most frequent in individuals older than 60 years; infrequent before the age of 40. Males have a very slightly greater risk than females.
6. Family History & Race
Risk is slightly elevated with a first-degree relative having multiple myeloma. African Americans have almost double the risk than Caucasians.
7. Obesity & Diet
Excess body weight is associated with increased risk of myeloma. Certain research indicates that chronic inflammation due to obesity is believed to cause the disease.
Multiple Myeloma Etiology
Multiple myeloma develops from the unrestrained growth of neoplastic plasma cells in the bone marrow, resulting in overproduction of aberrant monoclonal (M) proteins. The definite reason is not yet clear, but multiple myeloma etiology is thought to be polyfactorial with respect to genetics, environment, and immunity.
1. Genetic Factors
Numerous genetic abnormalities have been implicated in the pathogenesis of multiple myeloma:
Chromosomal translocations:
t(11;14), t(4;14), t(14;16), t(14;20) – involve the IgH gene (chromosome 14q32), resulting in oncogene activation.
Gene mutations:
Mutations in MYC, TP53, RAS (KRAS/NRAS), FGFR3, and BRAF are common in plasma cell malignancy.
Chromosome deletions & duplications:
17p deletion (del17p) is seen with aggressive disease and adverse prognosis. Gain of chromosome 1q (1q+) is associated with treatment resistance.
2. Precursor Conditions (Plasma Cell Dyscrasias)
Multiple myeloma frequently arises from preceding asymptomatic conditions: Monoclonal Gammopathy of Undetermined Significance (MGUS) A harmless condition where atypical plasma cells secrete monoclonal proteins.
1% of MGUS develop multiple myeloma per annum.
Smoldering Multiple Myeloma (SMM)
A more advanced precursor stage with a higher risk of disease progression (10% per year).
3. Environmental & Occupational Factors
Environmental exposure to some triggers is related to higher risk:
Exposure to radiation (e.g., survivors of the atomic bomb, radiation treatment)
Exposure to chemicals (e.g., benzene, herbicides, pesticides, Agent Orange)
Petroleum products and industrial chemicals
4. Immune Dysregulation & Chronic Inflammation
Chronic antigenic stimulation (due to infection or autoimmune disorder) can be stimulatory to plasma cell transformation.
Dysregulated cytokine function (IL-6, IL-1β, TNF-α) is responsible for myeloma cell survival.
5. Demographic & Lifestyle Risk Factors
Age: The majority are in older individuals (>60 years of age).
Sex: A slightly increased risk in men over women.
Race: African Americans have approximately double the risk compared to Caucasians.
Obesity: Increased inflammation and insulin resistance may be implicated in plasma cell proliferation.
6. Bone Marrow Microenvironment
Bone marrow niche establishes a survival niche in the form of a protective microenvironment for myeloma cells.
Interaction of stromal cells, osteoclasts, and cytokines (such as IL-6, VEGF, RANKL) facilitate tumor progression and bone resorption.
Multiple myeloma is a multistep disease involving genetic mutations, precursor disease (MGUS/SMM), environmental exposures, immune dysregulation, and bone marrow microenvironmental interactions. There is not a single cause but all of these factors in concert that propel plasma cell malignancy.
Multiple Myeloma Risk Factors
Multiple myeloma is a multifactorial condition, i.e., its etiology is determined by a combination of genetic, environmental, and lifestyle factors. The following are the major multiple myeloma risk factors linked to the disease:
1. Age
The strongest risk factor.
Most of the cases present in individuals above 60 years, with the median age at diagnosis being 69 years.
Uncommon before the age of 40.
2. Gender
Men have a slightly increased risk compared to women.
Cause is not known but possibly due to hormonal fluctuations or occupational exposures.
3. Race & Ethnicity
African Americans have a doubled risk of having multiple myeloma when compared to Caucasians.
There is less occurrence of the disease in the Hispanic and Asian populations.
4. Family History & Genetic Predisposition
First-degree relative (parent, sibling) with multiple myeloma doubles the risk 2-4 fold.
There may be inherited genetic alterations related to immune function and plasma cell growth.
Multiple myeloma is not very hereditary, however, and most are sporadic.
5. Precursor Plasma Cell Disorders
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Noncancerous disease where aberrant plasma cells produce monoclonal (M) proteins.
MGUS progresses to multiple myeloma in 1% of patients each year.
Smoldering Multiple Myeloma (SMM)
More advanced precursor condition with a 10% per year chance of progressing to multiple myeloma.
6. Environmental & Occupational Exposures
Radiation exposure:
Atomic bomb survivors and those with high radiation exposures are at increased risk.
Discover India’s best surgeons for cystogastrostomy, a minimally invasive surgery to drain pancreatic cysts. Expert care ensures faster recovery with high success rates and fewer complications.
Explore affordable Whipple’s procedure in India, offering expert gastro surgeons, advanced technology, and high success rates for pancreatic and bile duct cancer patients worldwide.
Explore the best hospitals in India for debridement surgery offering advanced wound care, expert surgeons, and affordable treatment options for international patients.
Experience fast recovery and affordable bilateral hernia treatment in India with expert surgeons, advanced techniques, and world-class hospital care for international patients.
Chest tube insertion in India ensures safe, affordable, and advanced care. Expert thoracic surgeons and modern facilities provide effective treatment for international patients.
Affordable & expert chronic pancreatitis treatment in India with GetWellGo. World-class care, trusted specialists & personalized support for international patients.
GetWellGo connects international patients to India’s best hospitals for ruptured appendix surgery. Safe, affordable, and expert care tailored to your needs.
GetWellGo provides world-class stem cell therapy for autism in children. Comprehensive support and care for international patients seeking effective treatment.